Surgical management of oligometastatic recurrence in primary esophageal melanoma: a feasible approach in resource-limited settings

Primary esophageal melanoma (PEM) is a rare and aggressive malignancy with limited treatment options. Due to its rarity, no standardized guidelines exist for managing oligometastatic recurrence, particularly in resource-limited settings. We present a case of a 60-year-old male with PEM who underwent esophagectomy followed by surgical resection of an adrenal metastasis. Despite the increasing use of immunotherapy, surgical resection remains a viable alternative for oligometastatic recurrence when access to systemic therapies is restricted. This case highlights the feasibility of surgery in achieving long-term disease control in select patients. Further studies are needed to establish evidence-based strategies for treating PEM recurrence in resource-constrained environments.

Authors

Institutions

Publication Details

Journal
Journal of Surgical Case Reports
Published
2025-03-01
DOI
https://doi.org/10.1093/jscr/rjaf123
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Surgical management of oligometastatic recurrence in primary esophageal melanoma: a feasible approach in resource-limited settings

Yurii Kondratskyi, Oleksii Dobrzhanskyi, A. V. Kolesnyk, Mykhailo Krotevych et al.
Journal of Surgical Case Reports
Cancer Immunotherapy and Biomarkers
article

Surgical management of oligometastatic recurrence in primary esophageal melanoma: a feasible approach in resource-limited settings

Yurii Kondratskyi, Oleksii Dobrzhanskyi, A. V. Kolesnyk, Mykhailo Krotevych, Y. Shudrak, Andrii Horodetskyi, Mykyta Pepenin
article en

Abstract

Primary esophageal melanoma (PEM) is a rare and aggressive malignancy with limited treatment options. Due to its rarity, no standardized guidelines exist for managing oligometastatic recurrence, particularly in resource-limited settings. We present a case of a 60-year-old male with PEM who underwent esophagectomy followed by surgical resection of an adrenal metastasis. Despite the increasing use of immunotherapy, surgical resection remains a viable alternative for oligometastatic recurrence when access to systemic therapies is restricted. This case highlights the feasibility of surgery in achieving long-term disease control in select patients. Further studies are needed to establish evidence-based strategies for treating PEM recurrence in resource-constrained environments.

Journal of Surgical Case ReportsVol. 2025(3)
National Cancer Institute (UA)
Openalex Percentile: Top 93%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.